{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:35:50Z","timestamp":1782452150068,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00399\u201320"],"award-info":[{"award-number":["APQ-00399\u201320"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.molimm.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T04:26:56Z","timestamp":1653280016000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model"],"prefix":"10.1016","volume":"147","author":[{"given":"Emerson","family":"de Castro Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"de Souza Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrian Morato","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilson","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Campos","family":"de Melo Iani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Caroline Zampiroli","family":"Ataide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Maciel","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Guerra","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Ligorio","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2022.05.012_bib1","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1038\/s41467-020-19883-7","article-title":"SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication","volume":"11","author":"Alexandersen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2022.05.012_bib2","first-page":"18","article-title":"Development of a new hydrogen peroxide-based vaccine platform","author":"Amanna","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2022.05.012_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01310652","article-title":"Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine","volume":"80","author":"Barteling","year":"1984","journal-title":"Archives of Virology"},{"key":"10.1016\/j.molimm.2022.05.012_bib4","first-page":"62","article-title":"A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model","author":"Bell","year":"1994","journal-title":"Pathobiology"},{"key":"10.1016\/j.molimm.2022.05.012_bib5","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2022.05.012_bib6","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","author":"Chai","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molimm.2022.05.012_bib7","first-page":"21","article-title":"Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells","author":"Choi","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.molimm.2022.05.012_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2011.08.027","article-title":"Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions","volume":"44","author":"Chu","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molimm.2022.05.012_bib9","first-page":"48","article-title":"Evaluation of the applicability of swiss webster lineage on the biological potency test of recombinant human erythropoietin","volume":"1","author":"Costa","year":"2010","journal-title":"Int. J. Biosaf. Biosecurity"},{"key":"10.1016\/j.molimm.2022.05.012_bib10","first-page":"11","article-title":"In situ RT-PCR optimized for electron microscopy allows description of subcellular morphology of target mRNA-expressing cells in the brain","author":"Cubas-Nu\u00f1ez","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molimm.2022.05.012_bib11","first-page":"1","article-title":"COVID-19 and Hyperimmune sera: a feasible plan B to fight against coronavirus","volume":"90","author":"da Costa Camila","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.molimm.2022.05.012_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2022.05.012_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2004.06.006","article-title":"Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV","volume":"121","author":"Darnell","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.molimm.2022.05.012_bib14","first-page":"40","article-title":"Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccines","author":"Delrue","year":"2009","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2022.05.012_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/erv.12.38","article-title":"Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges","volume":"11","author":"Delrue","year":"2012","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.molimm.2022.05.012_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-2438-7_10","article-title":"Purification of coronavirus virions for Cryo-EM and proteomic analysis","author":"Dent","year":"2015","journal-title":"Corona.: Methods Protoc."},{"issue":"4","key":"10.1016\/j.molimm.2022.05.012_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/jcm.16.4.704-708.1982","article-title":"Inactivation of lassa, marburg, and ebola viruses by gamma irradiation","volume":"16","author":"Elliott","year":"1982","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.molimm.2022.05.012_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/pathogens11020271","article-title":"Methods of inactivation of highly pathogenic viruses for molecular, serology or vaccine development purposes","volume":"11","author":"Elveborg","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.molimm.2022.05.012_bib19","doi-asserted-by":"crossref","first-page":"e00038","DOI":"10.1128\/JVI.00038-17","article-title":"Beta-propiolactone inactivation of coxsackievirus A16 induces structural alteration and surface modification of viral capsids","volume":"91","author":"Fan","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2022.05.012_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/vox.13091","article-title":"COVID-19 convalescent plasma therapy: hit fast, hit hard!","volume":"116","author":"Focosi","year":"2021","journal-title":"Vox Sang."},{"key":"10.1016\/j.molimm.2022.05.012_bib21","doi-asserted-by":"crossref","DOI":"10.15190\/d.2021.1","article-title":"First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization","volume":"9","author":"Fortner","year":"2021","journal-title":"Discoveries"},{"key":"10.1016\/j.molimm.2022.05.012_bib22","article-title":"Safety and effectiveness of the new inactivated hepatitis A virus vaccine","author":"Furesz","year":"1995","journal-title":"CMAJ"},{"key":"10.1016\/j.molimm.2022.05.012_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/icb.2011.70","article-title":"Return of inactivated whole-virus vaccine for superior efficacy","volume":"90","author":"Furuya","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molimm.2022.05.012_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molimm.2022.05.012_bib25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/jb.172.4.2141-2149.1990","article-title":"Evaluation of freeze-substitution and conventional embedding protocols for routine electron microscopic processing of eubacteria","volume":"172","author":"Graham","year":"1990","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2022.05.012_bib26","first-page":"53","article-title":"Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria","author":"Heinz","year":"2008","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.molimm.2022.05.012_bib27","first-page":"1630","article-title":"Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize","volume":"37","author":"Herrera-Rodriguez","year":"2019","journal-title":"Vaccin. Prod. Vaccin."},{"issue":"7","key":"10.1016\/j.molimm.2022.05.012_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/v8070204","article-title":"Inactivation of RNA viruses by gamma irradiation: a study on mitigating factors","volume":"8","author":"Hume","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.molimm.2022.05.012_bib29","volume":"1","author":"International Atomic Energy Agency Convention on the physical protection of nuclear material and nuclear facilities IAEA","year":"2016","journal-title":"INFCIRC\/274\/Rev. 1\/Mod."},{"key":"10.1016\/j.molimm.2022.05.012_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1097-0290(20001205)70:5<507::AID-BIT5>3.0.CO;2-C","article-title":"Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens","volume":"70","author":"Jiang","year":"2000","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.molimm.2022.05.012_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Ke","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.05.012_bib32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0264-410X(98)80116-3","article-title":"Vaccination with glutaraldehyde-fixed bovine respiratory syncytial virus (BRSV)- infected cells stimulates a better immune response in lambs than vaccination with heat-inactivated cell-free BRSV","author":"Keles","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2022.05.012_bib33","first-page":"25","article-title":"The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans","author":"Kistner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2022.05.012_bib34","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/JVI.03212-15","article-title":"Analyses of coronavirus assembly interactions with interspecies membrane and nucleocapsid protein chimeras","volume":"90","author":"Kuo","year":"2016","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.molimm.2022.05.012_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1191\/0960327102ht245oa","article-title":"Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse","volume":"21","author":"Le Nedelec","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.molimm.2022.05.012_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejps.2011.05.008","article-title":"Evaluation of water-in-oil-in-water multiple emulsion and microemulsion as potential adjuvants for immunization with rabies antigen","volume":"43","author":"Leclercq","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.molimm.2022.05.012_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/d41586-021-00650-7","article-title":"COVID antibody treatments show promise for preventing severe disease","volume":"591","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2022.05.012_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1186\/s12879-021-06568-9","article-title":"Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2022.05.012_bib39","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1745-7254.2005.00210.x","article-title":"Preparation and development of equine hyperimmune globulin F(ab\u2019) 2 against severe acute respiratory syndrome coronavirus","volume":"26","author":"Lu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.molimm.2022.05.012_bib40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/v7020666","article-title":"Evaluation of virus inactivation by formaldehyde to enhance biosafety of diagnostic electron microscopy","volume":"7","author":"M\u00f6ller","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.molimm.2022.05.012_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104868","article-title":"Immunoglobulin fragment F(ab\u2019)2 against RBD potently neutralizes SARS-CoV-2 in vitro","volume":"182","author":"Pan","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.molimm.2022.05.012_bib42","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020","volume":"25","author":"Perera","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.molimm.2022.05.012_bib43","first-page":"1","article-title":"Convalescent plasma or hyperimune immunoglobulin for people with COVID-19: a living systematic review (review)","author":"Piechotta","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molimm.2022.05.012_bib44","first-page":"16","article-title":"Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines","volume":"72","author":"Pollock","year":"1982","journal-title":"Cornell Vet."},{"key":"10.1016\/j.molimm.2022.05.012_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/vim.2010.0028","article-title":"Immunogenicity and protective efficacy in mice and hamsters of a \u03b2-propiolactone inactivated whole virus SARS-CoV vaccine","volume":"23","author":"Roberts","year":"2010","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2022.05.012_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1099\/00222615-20-1-123","article-title":"Morphological response of human rotavirus to ultra-violet radiation, heat and disinfectants","volume":"20","author":"Rodgers","year":"1985","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2022.05.012_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.molimm.2022.05.012_bib48","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1128\/JVI.72.10.7992-8001.1998","article-title":"Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins","volume":"72","author":"Rossio","year":"1998","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.molimm.2022.05.012_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1083\/jcb.17.1.19","article-title":"Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation","volume":"17","author":"Sabatini","year":"1963","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molimm.2022.05.012_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2074","article-title":"Inactivation methods for whole influenza vaccine production","volume":"29","author":"Sabbaghi","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.molimm.2022.05.012_bib51","first-page":"83","article-title":"A review of theoretical, experimental, and practical considerations in the use of formaldehyde for the inactivation of poliovirus","author":"Salk","year":"1960","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2022.05.012_bib52","first-page":"23","article-title":"An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application","author":"Samina","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2022.05.012_bib53","unstructured":"Skykes, G., 1965. The theory and mode of action of disinfection, in: Disinfection and Sterilization. LIPPINCOTT, PHILADELPHIA."},{"issue":"2316\u20132331","key":"10.1016\/j.molimm.2022.05.012_bib54","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2022.05.012_bib55","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1016\/j.vaccine.2007.07.060","article-title":"Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains","volume":"25","author":"Tano","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2022.05.012_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2020.4794","article-title":"Approaches towards fighting the COVID-19 pandemic (review)","volume":"47","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.molimm.2022.05.012_bib57","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41592-018-0224-7","article-title":"Comparing phenotypic variation between inbred and outbred mice","volume":"15","author":"Tuttle","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molimm.2022.05.012_bib58","doi-asserted-by":"crossref","first-page":"36198","DOI":"10.1074\/jbc.M111.279232","article-title":"Reactions of \u03b2-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses","volume":"286","author":"Uittenbogaard","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.molimm.2022.05.012_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molimm.2022.05.012_bib60","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/eji.202049072","article-title":"High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2","volume":"51","author":"Vanhove","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2022.05.012_bib61","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00284-021-02413-z","article-title":"Ongoing COVID-19 pandemic: a concise but updated comprehensive review","volume":"78","author":"Wang","year":"2021","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.molimm.2022.05.012_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.720315","article-title":"Significance of high-containment biological laboratories performing work during the COVID-19 pandemic: biosafety level-3 and -4 labs","volume":"9","author":"Yeh","year":"2021","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022002206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589022002206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:44:47Z","timestamp":1758980687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589022002206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":62,"alternative-id":["S0161589022002206"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2022.05.012","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}